Treatment for sickle cell disease in Africa: should we invest in haematopoietic stem cell transplantation?
Sickle Cell Disease (SCD) is a multi-organ haemoglobinopathy with the greatest disease burden in sub-Saharan Africa. Hydroxyurea is the only available drug treatment for SCD, its major drawback being a reasonable proportion of non-responsive patient and the resistance of some patients/parents to com...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Pan African Medical Journal
2014-05-01
|
| Series: | The Pan African Medical Journal |
| Subjects: | |
| Online Access: |
https://www.panafrican-med-journal.com/content/article/18/46/pdf/46.pdf
|